Milligan Michael Lee
SEC insider (Form 3/4/5 filer). CIK 0001993953. Officer at Neumora Therapeutics, Inc. (NMRA). 23 reported Form 4/5 transactions since Sep 2024; latest on Aug 20, 2026. Located in WATERTOWN, MA.
Companies Milligan Michael Lee has filed insider reports for
- Neumora Therapeutics, Inc. (NMRA): Officer, See Remarks
Milligan Michael Lee
CIK: 0001993953
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Neumora Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (23 total)
- Aug 20, 2026NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
175K shares- - Feb 17, 2026NMRA
Neumora Therapeutics, Inc.
SaleDirect1.4K shares at avg. $3.56$5K - Jan 8, 2026NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
350K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
38.2K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
85.4K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
400K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
28.7K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
85.4K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
38.2K shares- - May 28, 2025NMRA
Neumora Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
41.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 20, 2026 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 175,000 | - | - | Direct |
| Feb 17, 2026 | NMRA Neumora Therapeutics, Inc. | Sale | 1,436 | $3.56 | $5,119 | Direct |
| Jan 8, 2026 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 350,000 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 38,234 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Award Stock Option (Right to Buy) | 85,391 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 400,000 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 28,675 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 85,391 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 38,234 | - | - | Direct |
| May 28, 2025 | NMRA Neumora Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 41,250 | - | - | Direct |
1-10 of 23 transactions